These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 3240024)
1. A new procedure for studying central acting cardiovascular drugs: the permeabilization of the blood-brain barrier. Feldman J; Bousquet P Arch Int Pharmacodyn Ther; 1988; 296():7-17. PubMed ID: 3240024 [TBL] [Abstract][Full Text] [Related]
2. [Central hypotensive effect involving neurotransmitters of long-term administration of taurine to stroke-prone spontaneously hypertensive rat]. Yoshioka M; Takasugi Y; Koga Y Masui; 2007 Feb; 56(2):139-47. PubMed ID: 17315726 [TBL] [Abstract][Full Text] [Related]
3. Blood-brain barrier disruption and methotrexate in the treatment of a readily transplantable intracerebral osteogenic sarcoma of rats. Cosolo W; Christophidis N Cancer Res; 1987 Dec; 47(23):6225-8. PubMed ID: 3119195 [TBL] [Abstract][Full Text] [Related]
4. GABAB-ergic stimulation in hypothalamic pressor area induces larger sympathetic and cardiovascular depression in spontaneously hypertensive rats. Takenaka K; Sasaki S; Uchida A; Fujita H; Nakamura K; Ichida T; Itoh H; Nakata T; Takeda K; Nakagawa M Am J Hypertens; 1996 Oct; 9(10 Pt 1):964-72. PubMed ID: 8896648 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma. Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645 [TBL] [Abstract][Full Text] [Related]
6. The central actions of nicotine on blood pressure and heart rate after administration via the left vertebral artery of anaesthetized cats. Distribution of nicotine into the brain after central application. Porsius AJ; Van Zwieten PA Arzneimittelforschung; 1978; 28(9):1628-31. PubMed ID: 582567 [TBL] [Abstract][Full Text] [Related]
7. Central cardiovascular effects of a noncatecholamine endogenous ligand for clonidine receptors. Bousquet P; Feldman J; Atlas D J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S167-71. PubMed ID: 2455173 [TBL] [Abstract][Full Text] [Related]
8. The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats. Kaya M; Gulturk S; Elmas I; Kalayci R; Arican N; Kocyildiz ZC; Kucuk M; Yorulmaz H; Sivas A Life Sci; 2004 Nov; 76(2):201-12. PubMed ID: 15519365 [TBL] [Abstract][Full Text] [Related]
9. Central action of beta-adrenoceptor antagonists on blood pressure after acute administration in rats. Davy M; Midol-Monnet M; Heimburger M; Wepierre J; Cohen Y J Pharmacol; 1986; 17(1):28-36. PubMed ID: 2872366 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study. Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031 [TBL] [Abstract][Full Text] [Related]
11. Time course of hyperosmolar opening of the blood-brain and blood-CSF barriers in spontaneously hypertensive rats. Al-Sarraf H; Ghaaedi F; Redzic Z J Vasc Res; 2007; 44(2):99-109. PubMed ID: 17191032 [TBL] [Abstract][Full Text] [Related]
12. Intracarotid infusion of hypertonic mannitol changes permeability of blood-brain barrier to methotrexate in rats. Pan GY; Liu XD; Liu GQ Acta Pharmacol Sin; 2000 Jul; 21(7):613-6. PubMed ID: 11360668 [TBL] [Abstract][Full Text] [Related]
13. [Intra-arterial chemotherapy of malignant glioma after osmotic blood-brain barrier disruption]. Yamada K; Takahama H; Nakai O; Takanashi T; Hosoya T Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2692-6. PubMed ID: 2506817 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and ventilatory effects of taurine and homotaurine in anaesthetized rats. Paakkari P; Paakkari I; Karppanen H; Halmekoski J; Paasonen MK Med Biol; 1982 Dec; 60(6):316-22. PubMed ID: 7162225 [TBL] [Abstract][Full Text] [Related]
15. General pharmacology of the novel centrally acting antihypertensive agent moxonidine. Armah BI; Hofferber E; Stenzel W Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383 [TBL] [Abstract][Full Text] [Related]
16. Clonidine's central hypotensive effect: route of administration and localization in cat brain. McConnaughey MM; Ingenito AJ J Cardiovasc Pharmacol; 1982; 4(3):475-85. PubMed ID: 6177946 [No Abstract] [Full Text] [Related]
17. Increased brain uptake and brain to blood efflux transport of 14C-GABA in spontaneously hypertensive rats. Al-Awadi M; Pavlik A; Al-Sarraf H Life Sci; 2006 Jul; 79(9):847-53. PubMed ID: 16616765 [TBL] [Abstract][Full Text] [Related]
18. Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies. Neuwelt EA; Glasberg M; Frenkel E; Barnett P Ann Neurol; 1983 Sep; 14(3):316-24. PubMed ID: 6195955 [TBL] [Abstract][Full Text] [Related]
19. Centrally induced cardiovascular effects and kinetic behaviour of isoarecaidine propyl ester in the cat. Porsius AJ; Lambrecht G; Moser U; Mutschler E Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):22-35. PubMed ID: 7092417 [TBL] [Abstract][Full Text] [Related]
20. Evans blue distribution in the rate brain after intracarotid injection with the blood-brain barrier intact and open to osmosis. Kozler P; Pokorný J Sb Lek; 2003; 104(3):255-62. PubMed ID: 15224531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]